DETAILS, FICTION AND PONSEGROMAB

These trials confirmed clinically sizeable pharmacokinetic interactions [7] characterized by a lower during the clearance from the anticancer drug and for this reason amplified publicity. The interpretation of subsequent section II and III clinical trials was complex since it was impossible to administer exactly the same dose of chemotherapy while